FIBROSARCOMA NOS

Clinical trials for FIBROSARCOMA NOS explained in plain language.

Never miss a new study

Get alerted when new FIBROSARCOMA NOS trials appear

Sign up with your email to follow new studies for FIBROSARCOMA NOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Hope for rare childhood cancer: new drug combo aims to control soft tissue sarcoma

Disease control Recruiting now

This study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. The goal is to see if adding the targeted drug pazopanib (and another drug, selinexor, for high-risk patients) to standard chemotherapy and radiation can…

Matched conditions: FIBROSARCOMA NOS

Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated May 26, 2026 08:27 UTC

FIBROSARCOMA NOS

Get alerted when new FIBROSARCOMA NOS trials appear

Hope for rare childhood cancer: new drug combo aims to control soft tissue sarcoma